Plain-English translation of NCT06071910 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a procedure called REBOA (resuscitative endovascular balloon occlusion of the aorta) — a special balloon catheter that can be quickly inserted into the main blood vessel of the body during a cardiac emergency. Researchers want to know if using this balloon, alongside standard CPR, can help save more lives when someone's heart stops beating outside of a hospital. The study will enroll 40 patients in England to see whether this treatment is safe and works well enough to test in larger trials.
Survival rates from out-of-hospital cardiac arrest in England are much lower than in other countries — only about 8.6% compared to 14–21% elsewhere. This trial exists to explore whether this new balloon technique can improve blood flow to the brain and heart during resuscitation, giving patients a better chance of surviving and recovering.
You likely qualify if…
You likely don't qualify if…
If you qualify and are enrolled, you would receive the balloon catheter procedure as part of your emergency resuscitation care — this happens during the emergency itself, not at a separate visit. The research team will monitor how the procedure works, whether it improves blood flow during your resuscitation, and how you recover afterward. Your participation helps doctors understand if this technique is ready to be tested in larger studies to help future cardiac arrest patients.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United Kingdom